+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biopharmaceutical Bioseparation Systems Market by Type, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010879
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopharmaceutical Bioseparation Systems Market grew from USD 15.10 billion in 2023 to USD 16.48 billion in 2024. It is expected to continue growing at a CAGR of 9.49%, reaching USD 28.49 billion by 2030.

Biopharmaceutical bioseparation systems are critical processes employed in the purification and isolation of biological products such as vaccines, proteins, antibodies, and nucleic acids from complex mixtures, ensuring product safety and efficacy. The necessity of these systems lies in their ability to meet stringent regulatory requirements and improve the downstream processing efficiency, which is imperative for the scalable production of biologics. Bioseparation technologies are widely applied in the pharmaceutical and biopharmaceutical industries, hospitals, research institutions, and food & beverage sectors. End-use scope extends to contract manufacturing organizations (CMOs) and academic research.

The market for biopharmaceutical bioseparation systems is significantly influenced by the rising demand for biologics, advancements in personalized medicine, and the increasing global prevalence of chronic diseases. Key growth factors include technological innovations, such as membrane filtration, centrifugation, and chromatography, which enhance separation efficiency and reduce operational costs. Opportunities abound in emerging markets where pharmaceutical manufacturing infrastructures are rapidly expanding, alongside technological advancements such as single-use technologies and continuous bioprocessing offering potential for innovation. Firms can seize opportunities through strategic partnerships and investments in R&D to develop cost-effective, scalable bioseparation solutions.

However, market growth faces challenges due to high initial investment costs, stringent regulatory landscapes, and the complexities involved in scaling up bioprocesses. Intellectual property rights and intense competition further compound these challenges. Areas ripe for innovation include the development of hybrid separation techniques, integration of AI and IoT in process optimization, and enhancing the sustainability of bioseparation processes through eco-friendly materials and energy-efficient systems.

In-depth research should focus on optimizing separation efficiency and reducing waste output, aligning with environmental standards. The market is poised for growth driven by scientific advancements and unmet therapeutic needs, but strategically overcoming existing barriers will be vital for sustained success and competitive advantage in the dynamic biopharmaceutical landscape.

Understanding Market Dynamics in the Biopharmaceutical Bioseparation Systems Market

The Biopharmaceutical Bioseparation Systems Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing demand for biopharmaceuticals and personalized medicines
    • Government initiatives to boost domestic pharmaceutical industry
    • Growing popularity and importance of targeted therapies
  • Market Restraints
    • High initial investments and operating costs of bioseparation equipment
  • Market Opportunities
    • Growing investments in bioseparation companies and technologies
    • Rising advancements in biopharmaceutical separation technologies
  • Market Challenges
    • Regulatory challenges and complex validation processes

Exploring Porter’s Five Forces for the Biopharmaceutical Bioseparation Systems Market

Porter’s Five Forces framework further strengthens the insights of the Biopharmaceutical Bioseparation Systems Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Biopharmaceutical Bioseparation Systems Market

External macro-environmental factors deeply influence the performance of the Biopharmaceutical Bioseparation Systems Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Biopharmaceutical Bioseparation Systems Market

The Biopharmaceutical Bioseparation Systems Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biopharmaceutical Bioseparation Systems Market

The Biopharmaceutical Bioseparation Systems Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Biopharmaceutical Bioseparation Systems Market

The Biopharmaceutical Bioseparation Systems Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Bioseparation Systems Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Alfa Wassermann, Inc., Asahi Kasei Medical Co., Ltd., Astrea Bioseparations Limited, Bio-Rad Laboratories, Inc., Danaher Corporation, Flottweg SE, GEA Group Aktiengesellschaft, GL Sciences Inc., Hitachi High-Tech Corporation., Jasco Pty Ltd., KNAUER Wissenschaftliche Geräte GmbH, Merck KGaA, Novasep Holding SAS, PerkinElmer Inc., Repligen Corporation, Restek Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Bioscience LLC, Waters Corporation, and YMC Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Bioseparation Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Cell Disruption Technology
    • Centrifuges Technology
    • Chromatography Technique
    • Electrophoresis
    • Extraction Technique
    • Filtration Technology
    • Membrane-based
    • Precipitation
  • End-user
    • Biopharmaceutical Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for biopharmaceuticals and personalized medicines
5.1.1.2. Government initiatives to boost domestic pharmaceutical industry
5.1.1.3. Growing popularity and importance of targeted therapies
5.1.2. Restraints
5.1.2.1. High initial investments and operating costs of bioseparation equipment
5.1.3. Opportunities
5.1.3.1. Growing investments in bioseparation companies and technologies
5.1.3.2. Rising advancements in biopharmaceutical separation technologies
5.1.4. Challenges
5.1.4.1. Regulatory challenges and complex validation processes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Biopharmaceutical Bioseparation Systems Market, by Type
6.1. Introduction
6.2. Cell Disruption Technology
6.3. Centrifuges Technology
6.4. Chromatography Technique
6.5. Electrophoresis
6.6. Extraction Technique
6.7. Filtration Technology
6.8. Membrane-based
6.9. Precipitation
7. Biopharmaceutical Bioseparation Systems Market, by End-user
7.1. Introduction
7.2. Biopharmaceutical Companies
7.3. Research Institutes
8. Americas Biopharmaceutical Bioseparation Systems Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biopharmaceutical Bioseparation Systems Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Biopharmaceutical Bioseparation Systems Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET DYNAMICS
TABLE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL DISRUPTION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGES TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY EXTRACTION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY FILTRATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 106. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Biopharmaceutical Bioseparation Systems market, which are profiled in this report, include:
  • 3M Company
  • Agilent Technologies, Inc.
  • Alfa Wassermann, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Astrea Bioseparations Limited
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Flottweg SE
  • GEA Group Aktiengesellschaft
  • GL Sciences Inc.
  • Hitachi High-Tech Corporation.
  • Jasco Pty Ltd.
  • KNAUER Wissenschaftliche Geräte GmbH
  • Merck KGaA
  • Novasep Holding SAS
  • PerkinElmer Inc.
  • Repligen Corporation
  • Restek Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience LLC
  • Waters Corporation
  • YMC Co., Ltd.

Methodology

Loading
LOADING...

Table Information